TODARO, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.352
EU - Europa 828
AS - Asia 394
AF - Africa 20
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 2.605
Nazione #
US - Stati Uniti d'America 1.343
CN - Cina 257
DE - Germania 148
IT - Italia 139
SE - Svezia 106
IE - Irlanda 93
AT - Austria 77
SG - Singapore 54
DK - Danimarca 50
UA - Ucraina 45
FR - Francia 42
GB - Regno Unito 30
IN - India 21
FI - Finlandia 19
CH - Svizzera 14
SN - Senegal 14
BY - Bielorussia 13
VN - Vietnam 13
BE - Belgio 12
JP - Giappone 12
CA - Canada 9
ES - Italia 9
HK - Hong Kong 9
PL - Polonia 9
KR - Corea 8
RU - Federazione Russa 7
NL - Olanda 6
TH - Thailandia 5
AU - Australia 4
EU - Europa 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
RS - Serbia 3
TR - Turchia 3
UZ - Uzbekistan 3
CZ - Repubblica Ceca 2
PH - Filippine 2
RO - Romania 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BR - Brasile 1
CI - Costa d'Avorio 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
NZ - Nuova Zelanda 1
Totale 2.605
Città #
Chandler 271
Beijing 140
Ann Arbor 105
Dublin 93
Vienna 71
Ashburn 67
Dearborn 63
Torino 62
Fairfield 61
Nyköping 46
Wilmington 46
Houston 39
Singapore 39
Woodbridge 37
Jacksonville 36
Medford 35
Redwood City 30
Princeton 27
Fremont 22
Villeurbanne 21
Seattle 20
Guangzhou 19
San Mateo 17
Cambridge 16
New York 15
Brussels 12
Dong Ket 12
Pisa 12
Hefei 10
Shanghai 10
Turin 9
Chennai 8
Hangzhou 8
Norwalk 8
Oerlikon 8
Warsaw 8
Central District 7
Chengdu 7
Los Angeles 7
Nanjing 7
Falls Church 6
Linden 6
San Jose 6
Thening 6
Wayne 6
Boardman 5
Milan 5
Rome 5
Shenyang 5
Tokyo 5
Bologna 4
Boston 4
Erlangen 4
Philadelphia 4
Piemonte 4
Rochester 4
Santa Clara 4
Somerville 4
Wuhan 4
Zhengzhou 4
Balingen 3
Belgrade 3
Cape Town 3
Changsha 3
Fuzhou 3
Hamburg 3
Helsinki 3
Kunming 3
Langreo 3
Mortara 3
Nürnberg 3
Phoenix 3
San Diego 3
Swindon 3
Toronto 3
Bengaluru 2
Birmingham 2
Camden 2
Catanzaro 2
Changchun 2
Chicago 2
Dudley 2
Guiyang 2
Harbin 2
Jinan 2
Noventa Vicentina 2
Ocala 2
Paris 2
Pittsburgh 2
Prague 2
Pune 2
Seoul 2
Shaoxing 2
Sydney 2
Tampa 2
Washington 2
West Des Moines 2
Aachen 1
Abidjan 1
Amsterdam 1
Totale 1.718
Nome #
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. 347
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET 279
ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma 169
The influence of tissue ischemia time on RNA integrity and patient-derived xenografts (PDX) engraftment rate in a non-small cell lung cancer (NSCLC) Biobank 160
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 134
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 132
Magic pills: new oral drugs to treat chronic lymphocytic leukemia 130
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 106
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells, Also Overcoming Intrinsic and Stromal Cells-Mediated Fludarabine Resistance 102
Regulation of HIF-1α in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target 95
SELINEXOR (KPT-330) IN COMBINATION WITH CHEMOTHERAPY OR IDELALISIB ELICITS A SYNERGISTIC CYTOTOXIC EFFECT IN PRIMARY CLL CELLS, ALSO OVERCOMING INTRINSIC AND STROMAL CELLS-MEDIATED FLUDARABINE RESISTANCE 88
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia 81
HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target 78
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 72
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 70
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target 65
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells 64
Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms 63
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 62
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells 61
REGULATION OF HIF-1 IN TP53 DISRUPTED CLL CELLS AND ITS INHIBITION AS A STRATEGY TO OVERCOME FLUDARABINE RESISTANCE 61
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll 60
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 58
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET 49
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target 45
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells 35
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia 14
Totale 2.680
Categoria #
all - tutte 7.676
article - articoli 0
book - libri 0
conference - conferenze 4.248
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.924


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020476 0 0 37 54 38 68 48 37 49 65 36 44
2020/2021397 41 40 22 28 53 21 23 29 22 18 68 32
2021/2022421 24 6 12 42 26 9 35 24 11 42 117 73
2022/2023580 75 64 27 60 52 124 34 37 53 21 26 7
2023/2024242 28 46 9 8 16 44 12 18 8 14 12 27
2024/202550 8 27 15 0 0 0 0 0 0 0 0 0
Totale 2.680